Table 2.
Summary of comparisons and p values of the levels of the different T cell subsets analyzed in blood samples from patients with RA and healthy controls.
| Parameter compared (RA patients vs. controls) | Levels in RA | p value |
|---|---|---|
| Total Th17 cells (percentages) | Increased | <0.005 |
| Total Th17 cells (absolute numbers) | Increased | <0.05 |
| Pathogenic Th17 cells (percentages) | Increased | <0.005 |
| Pathogenic Th17 cells (absolute numbers) | Increased | <0.005 |
| Nonpathogenic Th17 cells (percentages) | Increased | <0.05 |
| Nonpathogenic Th17 cells (absolute numbers) | Increased | <0.05 |
| CXCR3+ Th22 cells (percentages) | Increased | <0.005 |
| CXCR3+ Th22 cells (absolute numbers) | Increased | <0.005 |
| CXCR3− Th22 cells (percentages) | Increased | <0.05 |
| CXCR3− Th22 cells (absolute numbers) | Increased | <0.05 |